COMBINATION THERAPY WITH AXL INHIBITOR AND IMMUNE CHECKPOINT MODULATOR OR ONCOLYTIC VIRUS

• 收藏
• 分享

专利权人:

BerGenBio ASA

发明人:

James Bradley LORENS,Gro GAUSDAL

申请号：

US15577804

公开号：

US20180153888A1

申请日:

2016.05.27

申请国别(地区):

US

年份:

2018

代理人:

摘要：

An Axl inhibitor and one or more immune checkpoint (activity) modulators and/or one or more oncolytic viruses, for use in the prevention, treatment or management of cancer, wherein the Axl inhibitor and the one or more immune checkpoint (activity) modulators and/or the one or more oncolytic viruses are administered concurrently, separately or sequentially； compositions containing such components in combination； and methods of treating cancer in a patient by administering such components in combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/